Matrix Metalloproteinases and Hypertension-Mediated Organ Damage: Current Insights

Valeria Bisogni,1,* Alberto Cerasari,1,2,* Giacomo Pucci,1,2 Gaetano Vaudo1,2 1Unit of Internal Medicine, Terni University Hospital, Terni, Italy; 2Department of Medicine, University of Perugia, Perugia, Italy*These authors contributed equally to this workCorrespondence: Valeria BisogniUnit of Inter...

Full description

Saved in:
Bibliographic Details
Main Authors: Bisogni V (Author), Cerasari A (Author), Pucci G (Author), Vaudo G (Author)
Format: Book
Published: Dove Medical Press, 2020-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_7579bb068b0541ef9b43267374a5fe5c
042 |a dc 
100 1 0 |a Bisogni V  |e author 
700 1 0 |a Cerasari A  |e author 
700 1 0 |a Pucci G  |e author 
700 1 0 |a Vaudo G  |e author 
245 0 0 |a Matrix Metalloproteinases and Hypertension-Mediated Organ Damage: Current Insights 
260 |b Dove Medical Press,   |c 2020-11-01T00:00:00Z. 
500 |a 1178-7104 
520 |a Valeria Bisogni,1,* Alberto Cerasari,1,2,* Giacomo Pucci,1,2 Gaetano Vaudo1,2 1Unit of Internal Medicine, Terni University Hospital, Terni, Italy; 2Department of Medicine, University of Perugia, Perugia, Italy*These authors contributed equally to this workCorrespondence: Valeria BisogniUnit of Internal Medicine, Terni University Hospital, Via Tristano di Joannuccio, 1, Terni, TR 05100, ItalyTel +39 0744 205328Email valeria.bisogni@hotmail.itAbstract: Matrix metalloproteinases (MMPs) are important extracellular enzymes involved in many physiological and pathological processes. Changes in the activity and concentration of specific MMPs, as well as the unbalance with their inhibitors (tissue inhibitors of metalloproteinases – TIMPs), have been described as a part of the pathogenic cascade promoted by arterial hypertension. MMPs are able to degrade various protein substrates in the extracellular matrix, to influence endothelial cells function, vascular smooth muscle cells migration, proliferation and contraction, and to stimulate cardiomyocytes changes. All these processes can be activated by chronically elevated blood pressure values. Animal and human studies demonstrated the key function of MMPs in the pathogenesis of hypertension-mediated vascular, cardiac, and renal damage, besides age and blood pressure values. Thus, the role of MMPs as biomarkers of hypertension-mediated organ damage and potential pharmacological treatment targets to prevent further cardiovascular and renal complications in hypertensive population is increasingly supported. In this review, we aimed to describe the main scientific evidence about the behavior of MMPs in the development of vascular, cardiac, and renal damage in hypertensive patients.Keywords: matrix metalloproteinases, arterial hypertension, hypertension-mediated organ damage 
546 |a EN 
690 |a matrix metalloproteinases 
690 |a arterial hypertension 
690 |a hypertension-mediated organ damage 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Integrated Blood Pressure Control, Vol Volume 13, Pp 157-169 (2020) 
787 0 |n https://www.dovepress.com/matrix-metalloproteinases-and-hypertension-mediated-organ-damage-curre-peer-reviewed-article-IBPC 
787 0 |n https://doaj.org/toc/1178-7104 
856 4 1 |u https://doaj.org/article/7579bb068b0541ef9b43267374a5fe5c  |z Connect to this object online.